ODDB.org: Open Drug Database

Swissmedic Registration	68512	Date of registration	31.08.2022
Company name	AstraZeneca AG	Revision date
		Valid until	30.08.2027
Indication		Date of market entry
Index Therapeuticus (BSV)	07.15.	Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Saphnelo 300 mg/2 ml	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Anifrolumabum 300mg / 2ml)	L04AG11

2025	©ywesee GmbH